PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,024,925 Value ($000) $89,517 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 1,085,564 Value ($000) $72,114 Avg Close $56.84 Range $49.38 - $68.26
Q4 2024
Shares 19,716 Value ($000) $761 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 315,373 Value ($000) $14,192 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 572,177 Value ($000) $19,826 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 976,893 Value ($000) $28,262 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 142,470 Value ($000) $3,267 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 21,747 Value ($000) $363 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 164,500 Value ($000) $4,543 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 1,366,080 Value ($000) $31,420 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 1,454,446 Value ($000) $15,868 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 814,726 Value ($000) $6,869 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 464,057 Value ($000) $3,671 Avg Close $12.09 Range $6.91 - $25.76
Q1 2021
Shares 86,691 Value ($000) $2,245 Avg Close $25.31 Range $18.82 - $32.10
Q4 2020
Shares 116,794 Value ($000) $2,354 Avg Close $21.52 Range $17.44 - $25.65
Q2 2019
Shares 17,799 Value ($000) $216 Avg Close $11.06 Range $8.88 - $13.14